VVOS
Vivos Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.19
+6.76%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.6x
Market Cap
$3.75M
MomentumView details →
1D Return
+6.76%
YTD Return
−91.26%
RSI (14)
26.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.6x
Market Cap
$3.75M
RSI (14)
26.7
MomentumView details →
1D Return
+6.76%
YTD Return
−91.26%
SummaryUpdated Jun 1, 2026
Vivos Therapeutics, Inc. (NASDAQ:VVOS) is a medical technology company founded in 2016 and based in Highlands Ranch, Colorado. The company went public in December 2020 and specializes in developing non-invasive treatment alternatives for patients suffering from dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring. Vivos has undergone significant strategic transformation since its founding, evolving from a dental-focused distribution model to a medical sleep center partnership approach, while maintaining its core focus on providing alternatives to traditional CPAP therapy for sleep apnea patients.
Similar companies
Latest newsMore news →
Vivos Therapeutics, Inc. held its Q2 2026 earnings call on August 14, 2026.21d agoVivos Therapeutics, Inc. entered into a securities purchase agreement for a PIPE offering of 3,608,496 units at $0.582 per unit, raising approximately $2.1 million, with each unit consisting of one share of Series A Convertible Preferred Stock and a five-year warrant.60d ago